Published by Josh White on 13th July 2021
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced preclinical data demonstrating that 'SFX-01' was effective in in-vitro models of certain blood cancers on Tuesday.
URL: http://www.digitallook.com/dl/news/story/31984484/...